ArticleCommunications biology2025
Dcaf15-mediated EphA2 degradation triggers disruption of the blood-brain barrier during Streptococcus suis meningitis.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pseudorabies virus pUL40 drives inflammatory signaling through competitive hijacking of EphA2 from the Akt-EphA2 interaction.Veterinary research · 2026Article
- Gut Microbiota-Derived Butyrate Strengthens Blood-Brain Barrier Integrity and Attenuates Streptococcus suis SC19-Induced Meningitis: Involvement of the Gut-Brain Axis.Transboundary and emerging diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Disruption of blood-brain barrier (BBB) is the critical step of Streptococcus suis (S. suis) meningitis. Here we show that Ephrin type-A receptor 2 (EphA2) plays an important role in BBB against S. suis meningitis. S. suis downregulates EphA2 and EphA2 deficiency aggravates S. suis-induced BBB disruption in vitro and in vivo. We identify that EphA2-mediated autophagy alleviates S. suis-induced BBB disruption. To destroy the protective effect of EphA2 in BBB, S. suis recruits E3 ligase DCAF15 to interact with EphA2, which induces EphA2 ubiquitination and degradation. Mechanically, DCAF15 promotes K48- and K63-linked ubiquitination of EphA2 at K646, K649 and K754. In addition, S. suis serine/threonine protein kinase (STK) is indispensable for EphA2 degradation. STK phosphorylates histone deacetylase SIRT1 at S48 to trigger the deacetylation of DCAF15, enhancing DCAF15-EphA2 interaction and promoting ubiquitinated degradation of EphA2, thereby disrupting BBB. Moreover, acetylation of DCAF15 at K552 and K581 sites is involved in mediating EphA2 ubiquitination and BBB stability. Our study suggests a protective role of EphA2 in S. suis-induced BBB disruption, which provides a valuable insight on the development of EphA2 as a potential therapeutic target to treat bacterial meningitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.